ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway

Sun, Xiaowei; Chen, Zhenhui; Yu, Lu; Zeng, Weisen; Sun, Boyuan; Fan, Hongying*; Bai, Yang*南方医科大学; y
Frontiers in Pharmacology2023-5-24DOI: 10.3389/fphar.2023.1205323
8阅读
引用收藏
分享

摘要

Background: The relationships among intestinal dysbiosis, bile acid (BA) metabolism disorders, and ulcerative colitis pathogenesis are now recognized. However, how specific strains regulate BA metabolism to alleviate colitis is still unclear. This study investigated the effects of Bacteroides dorei on the development of acute colitis and elucidated the underlying mechanisms. @@@ Methods: The safety of BDX-01 was evaluated in vitro and in vivo. 2.5% dextran sulfate sodium (DSS) induced colitis in C57BL/6 mice, Caco-2, and J774A.1 cells were used to evaluate the anti-inflammatory effect of BDX-01. qPCR and Western blotting were used to detect the expression of inflammatory pathways. Microbiota composition was analyzed by 16S rRNA gene sequencing. Enzyme activity analysis and targeted metabolomics were used to analyze fecal bile salt hydrolase (BSH) and BA levels. Antibiotic-induced pseudo-germ-free mice were used to investigate the role of gut microbiota in the alleviation of colitis by BDX-01. @@@ Results: We confirmed the safety of novel strain Bacteroides dorei BDX-01 in vitro and in vivo. Oral BDX-01 administration significantly ameliorated the symptoms and pathological damage of DSS-induced acute colitis. Moreoever, 16S rRNA sequencing and enzyme activity analysis showed that BDX-01 treatment increased intestinal BSH activity and the abundance of bacteria harboring this enzyme. Targeted metabolomics revealed that BDX-01 significantly increased intestinal BA excretion and deconjugation. Certain BAs act as FXR agonists. The beta-muricholic acid (beta MCA): taurine beta-muricholic acid (T-beta MCA) and cholic acid (CA): taurocholic acid (TCA) ratios and the deoxycholic acid (DCA) level decreased markedly in the colitis models but increased substantially in BDX-01-treated mice. The colonic farnesoid X receptor (FXR) and fibroblast growth factor 15 (FGF15) were upregulated in mice treated with BDX-01. BDX-01 downregulated the expression of colonic proinflammatory cytokines pyrin domain-containing 3 (NLRP3), ASC, cleaved caspase-1, and IL-1 beta. Antibiotic treatment didn't abolish the protective effect of BDX-01 on colitis. In vitro studies showed T beta MCA abolished the effects of BDX-01 on FXR activation and inhibition of the NLRP3 inflammasome activation. @@@ Conclusion: BDX-01 improved DSS-induced acute colitis by regulating intestinal BSH activity and the FXR-NLRP3 signaling pathway. Our findings indicate that BDX01 is a promising probiotic to improve the management of ulcerative colitis.

学科与关键词

关键词
Bacteroidesbile acidbile salt hydrolasefarnesoid X receptorinflammasomeprobioticulcerative colitis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2023-05-24
卷期
第 14 卷
页码
1205323
DOI
10.3389/fphar.2023.1205323
语言
ENGLISH
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province, China [2022A1515011230]; Clinical Research Project of Nanfang Hospital [2021CR008]

作者

  • S

    Sun, Xiaowei (第一作者)

    southern med univ

  • C

    Chen, Zhenhui

    southern med univ

查看全部 7 位作者收起作者
  • Y

    Yu, Lu

    southern med univ

  • Z

    Zeng, Weisen

    southern med univ

  • S

    Sun, Boyuan

    2 · southern med univ

  • F

    Fan, Hongying (通讯)

    southern med univ

  • B

    Bai, Yang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417